Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin...

PRGO : 57.42 (-1.17%)
SLGL : 7.52 (-3.09%)
BHC : 18.06 (-3.16%)
Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, 0.045%, In The United States

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the world, today...

BHC : 18.06 (-3.16%)
BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China

, /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that BAUSCH + LOMB ULTRA® monthly silicone hydrogel...

BHC : 18.06 (-3.16%)
Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Paul S. Herendeen, executive vice president and chief financial officer, , senior vice president and head of Investor...

BHC : 18.06 (-3.16%)
Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed...

BHC : 18.06 (-3.16%)
Bausch (BHC) Up 21.2% Since Last Earnings Report: Can It Continue?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BHC : 18.06 (-3.16%)
FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses

, /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received 510(k) clearance from the...

BHC : 18.06 (-3.16%)
Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses

, /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the European launch of the company's first Extended...

BHC : 18.06 (-3.16%)
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced and upsized its previously announced offering of ,000 aggregate principal...

BHC : 18.06 (-3.16%)
Bausch Health Announces Launch of Private Offering of Senior Notes and Conditional Redemption of Existing Senior Secured Notes

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of ,000 aggregate principal amount of new senior notes...

BHC : 18.06 (-3.16%)
Bausch (BHC) Down on Q1 Earnings & Sales Miss, View Trimmed

Bausch (BHC) misses on earnings and sales in the first quarter and lowers guidance due to the coronavirus pandemic.

ENDP : 3.55 (-0.84%)
NVS : 87.30 (-0.65%)
MNK : 2.87 (-7.42%)
BHC : 18.06 (-3.16%)
Endo (ENDP) Q1 Earnings Beat on Coronavirus-Led Stockpiling

Endo's (ENDP) earnings and sales beat estimates in the first quarter owing to increased customer inventory purchasing due to the COVID-19 pandemic

ENDP : 3.55 (-0.84%)
INFI : 0.8600 (+3.61%)
MNK : 2.87 (-7.42%)
BHC : 18.06 (-3.16%)
Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates

Bausch (BHC) delivered earnings and revenue surprises of -1.11% and -1.68%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

BHC : 18.06 (-3.16%)
Bausch Health Companies Inc. Announces First-Quarter 2020 Results

, /PRNewswire/ --

BHC : 18.06 (-3.16%)
Should You Buy Bausch Health (BHC) Ahead of Earnings?

Bausch Health (BHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BHC : 18.06 (-3.16%)
Bausch Health (BHC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Bausch (BHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BHC : 18.06 (-3.16%)
Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that  Joseph C. Papa, chairman and chief executive officer, and , senior vice president and head of Investor Relations...

BHC : 18.06 (-3.16%)
Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual Meeting

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed...

BHC : 18.06 (-3.16%)
Karyopharm Starts Dosing With Selinexor for Coronavirus Infection

Karyopharm (KPTI) doses the first patient in a phase II study evaluating the low dose of its drug Xpovio (selinexor) to treat hospitalized patients with severe COVID-19 infection. Shares up.

SNY : 52.83 (-0.83%)
RHHBY : 44.9085 (+0.96%)
KPTI : 19.09 (-1.60%)
BHC : 18.06 (-3.16%)
Bausch (BHC) Starts Study on Virazole for Coronavirus Infection

Bausch (BHC) begins a clinical study on Virazole in combination with standard-of-care therapy to treat adults with respiratory distress due to COVID-19 in Canada.

RHHBY : 44.9085 (+0.96%)
INCY : 101.30 (-2.83%)
NVS : 87.30 (-0.65%)
BHC : 18.06 (-3.16%)

Van Meerten Stock Picks

Ebay - Pick of the Day
Today Ebay (EBAY) is a Volume Leader on Barchart: 100% technical buy signals Trend Spotter buy signal Above its 20, 50 and 100 Day moving averages 16 new highs and up 26.
EBAY +0.42
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar